Comparative Effects of Injectable Biostimulatory Agents (Calcium Hydroxyapatite, New Cellular Treatment Factor, VAMP, and Human Exosomes) and Their Combination on Skin Regeneration
Aesthetic Surgery Journal Open Forum · 14.01.2026 · 8
DOI: 10.1093/asjof/ojag071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Surgery Journal Open Forum, online erschienen am 22.04.2026. Verfasst von Noury Adel und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Injectable biostimulatory and bioactive agents are increasingly used to enhance dermal regeneration and improve skin quality. Polydeoxyribonucleotide (PDRN), polyrevitalizing multicomponent solutions, calcium hydroxylapatite microspheres, and human-derived exosomes have been proposed to stimulate fibroblast activity, collagen remodeling, and angiogenesis. However, direct comparative evidence in intact skin remains limited.
Objectives
The aim of this study was to compare the histological and angiogenic effects of PDRN, polyrevitalizing solutions, calcium hydroxylapatite, human-derived exosomes, and their combination on dermal regeneration in intact skin using a hamster model.
Methods
One hundred and sixty-eight adult Syrian hamsters were randomized into 7 groups (n = 24/group): untreated control, saline control, polyrevitalizing solution, PDRN, exosomes, calcium hydroxylapatite, and combination therapy. All treatments were administered subcutaneously (0.1 mL per site). Skin samples were collected at days 3, 7, and 14 (n = 8/group/time point). Histological evaluation included hematoxylin–eosin, Masson's trichrome, and Van Gieson staining to assess dermal architecture and collagen organization. Angiogenesis was quantified using CD34 immunohistochemistry and microvessel density analysis.
Results
All active treatments increased dermal cellularity, collagen deposition, and microvessel density compared with control and saline groups. Combination therapy produced the greatest enhancements in collagen fiber density, organization, and angiogenesis, with significantly higher CD34-positive microvessel density at days 7 and 14 (P < .05 vs all single-agent groups). Among single agents, the polyrevitalizing solution (new cellular treatment factor) demonstrated the most pronounced overall regenerative response, followed by VAMP (PDRN), Radiesse, and adipose stem cell exosomes.
Conclusions
Injectable bioactive and biostimulatory agents enhance dermal remodeling and neovascularization in intact skin, with combination therapy targeting complementary regenerative pathways yielding the most pronounced histological effects. These findings support multimodal injectable strategies for skin rejuvenation and regenerative dermatology. Level of Evidence: 4 (Therapeutic)
Autor:innen und Institutionen
ORCID-Profile: Noury Adel
Zitieren
APA
Adel, N., Kolenda, J., Hernández Gómez Crespo, F., Zavala Resendiz, G. Y., Jo, Y. K., Thulesen, I. V., & Saucillo, J. R. (2026). Comparative Effects of Injectable Biostimulatory Agents (Calcium Hydroxyapatite, New Cellular Treatment Factor, VAMP, and Human Exosomes) and Their Combination on Skin Regeneration. Aesthetic Surgery Journal Open Forum, 8. https://doi.org/10.1093/asjof/ojag071
Vancouver
Adel N, Kolenda J, Hernández Gómez Crespo F, Zavala Resendiz GY, Jo YK, Thulesen IV, et al. Comparative Effects of Injectable Biostimulatory Agents (Calcium Hydroxyapatite, New Cellular Treatment Factor, VAMP, and Human Exosomes) and Their Combination on Skin Regeneration. Aesthetic Surgery Journal Open Forum. 2026;8. doi:10.1093/asjof/ojag071
BibTeX
@article{Adel2026,
author = {Adel, Noury and Kolenda, Jack and Hernández Gómez Crespo, Francisco and Zavala Resendiz, Gabriela Yareli and Jo, Youn Kyong and Thulesen, Ida Vega and Saucillo, Jose Ramon},
title = {Comparative Effects of Injectable Biostimulatory Agents (Calcium Hydroxyapatite, New Cellular Treatment Factor, VAMP, and Human Exosomes) and Their Combination on Skin Regeneration},
journal = {Aesthetic Surgery Journal Open Forum},
year = {2026},
volume = {8},
doi = {10.1093/asjof/ojag071}
}
EUVIMED